chr3-37017508-C-A

Variant summary

Our verdict is Pathogenic.
>+14 Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 24 classification points (ACMG Germline Pathogenicity v2019). PS3PS4_SupportingPM1PM2PM5PP1PP3_StrongPP5_Very_Strong

The NM_000249.4(MLH1):c.793C>A (p.Arg265Ser) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 7.28). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★★). ClinVar reports functional evidence for this variant: "SCV000106885: Paper by Van der Klift et al. 2015 shows aberrant splicing (exon 10 exclusion) in patient sample and minigene assay, confirmed by minigene assay in Soukarieh et al., 2016 (Plos Genet)." and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.R265V: Pathogenic (ClinVar VariationId 619508, 1 star) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.R265H: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 90381, 1 star); p.R265L: Uncertain_significance (ClinVar VariationId 1928288, 2 stars); p.R265= (synonymous): Likely_benign (ClinVar VariationId 491730, 2 stars) This exact variant is established as oncogenic in: CGI (Cancer Genome Interpreter). This exact variant is curated in the UniProt human variants database as Uncertain Significance, associated with Colorectal cancer, hereditary nonpolyposis, type 2 (hnpcc2); it is also listed as a COSMIC curated somatic variant.

Frequency

Genomes: not found (cov: 32)

Consequence

MLH1
NM_000249.4 missense, splice_region

Predictors

17
2
REVEL: 0.98 : Pathogenic

Clinical Significance

Pathogenic reviewed by expert panel P:10

Conservation

PhyloP100: 7.28

Publications

65 publications found
Genes affected
MLH1 (HGNC:7127): (mutL homolog 1) The protein encoded by this gene can heterodimerize with mismatch repair endonuclease PMS2 to form MutL alpha, part of the DNA mismatch repair system. When MutL alpha is bound by MutS beta and some accessory proteins, the PMS2 subunit of MutL alpha introduces a single-strand break near DNA mismatches, providing an entry point for exonuclease degradation. The encoded protein is also involved in DNA damage signaling and can heterodimerize with DNA mismatch repair protein MLH3 to form MutL gamma, which is involved in meiosis. This gene was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). [provided by RefSeq, Aug 2017]
MLH1 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen
  • Lynch syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics
  • Muir-Torre syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Genomics England PanelApp
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • Lynch syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
RPL29P11 (HGNC:36905): ()

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000249.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Pathogenic. The variant received 24 points.

PS3Functional studies show damaging effect
Well-established functional study supports damaging effect (PS3); SCV000106885: Paper by Van der Klift et al. 2015 shows aberrant splicing (exon 10 exclusion) in patient sample and minigene assay, confirmed by minigene assay in Soukarieh et al., 2016 (Plos Genet).; SCV000592379: However, functional studies including in vitro MMR complementation assays, protein expression assays, promoter methylation studies, LOH analysis, and a yeast-based reversion rate assay, suggests this variant is likely pathogenic (Drost_2010_20020535, Alemayehu_2008_18618713, Wanat_2007_17210669).; SCV000664835: This alteration is located in the ATP-binding domain of the MLH1 protein and has been demonstrated to reduce mismatch repair proficiency in two different yeast strains when compared to wildtype (Wanat JJ et al. Hum. Mol. Genet. 2007 Feb;16:445-52). In an in vitro complementation assay, this variant was determined to be functionally deficient (Drost M et al. Genet Med, 2019 07;21:1486-1496).; SCV001235949: RNA analysis indicates that this missense change induces altered splicing and may result in an absent or disrupted protein product. Studies have shown that this missense change results in skipping of exon 10 and introduces a premature termination codon (PMID: 26247049; Invitae).; SCV005883162: At least one publication reports experimental evidence that this variant affects mRNA splicing by causing skipping of exon 10 and causing a premature stop codon subject to nonsense mediated decay (vanderKlift_2015).
PS4Prevalence increased in affected individuals
Rare variant reported in affected individuals by ≥2 independent ClinVar submitters (PS4_Supporting); 5 ClinVar submitter(s) report the variant in affected individuals; SCV000106885: Paper by Van der Klift et al. 2015 shows aberrant splicing (exon 10 exclusion) in patient sample and minigene assay, confirmed by minigene assay in Soukarieh et al., 2016 (Plos Genet).; SCV000592379: It was identified in 3 out of 572 proband chromosomes (frequency 0.005) in individuals with colorectal cancer, however, no normal population controls were included in these studies. In one family the variant was shown to segregate with disease in 4 affected individuals with Lynch syndrome (two were obligate carriers), and did not segregate in at least two unaffected individuals, increasing the likelihood this variant is pathogenic.; SCV000664835: This mutation has been identified as germline in multiple individuals with Lynch syndrome, several whose tumors demonstrated high microsatellite instability and/or loss of MLH1/PMS2 proteins on immunohistochemistry (Zavodna K et al. Neoplasma. 2006;53:269-76; Niessen RC et al. Gut, 2006 Dec;55:1781-8; Alemayehu A et al. Genes Chromosomes Cancer. 2008 Oct;47:906-14; Hardt K et al. Fam. Cancer. 2011 Jun;10:273-84; Ferguson SE et al. Cancer. 2014 Dec;120:3932-9; van der Klift HM et al. Hum Mutat, 2016 11;37:1162-1179; Latham A et al. J Clin Oncol, 2019 02;37:286-295; Ambry internal data).; SCV001235949: This missense change has been observed in individuals with clinical features of Lynch syndrome (PMID: 21404117, 25081409, 27435373).; SCV005883162: The variant allele was found at a frequency of 4e-06 in 251460 control chromosomes. c.793C>A has been reported in the literature in individuals affected with Lynch Syndrome (Zavodna_2006, vanderKlift_2015, Hardt_2011, Ferguson_2014).
PM1Mutational hot spot or critical domain
Missense neighbourhood hotspot (≥2 P/LP within ±8 AA, OR ≥ 5 vs. background) — PM1; In-domain: 0 pathogenic, 0 benign rare missense variants; ±8 AA neighbourhood: 3 pathogenic, 3 benign (OR vs. background: 5.0)
PM2Absent/extremely low in population databases
Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD+AR) (base 0.0001, raised to 0.0005 by highest known P/LP ClinVar AF 0.000636) — PM2 moderate
PM5Novel missense at known pathogenic residue
Different pathogenic missense at same AA residue in ClinVar (PM5); ClinVar contains a germline Pathogenic/Likely Pathogenic entry at the same amino acid position with a different amino acid change: p.R265V: Pathogenic (ClinVar VariationId 619508, 1 star); Other variants at the same amino acid residue (not pathogenic): p.R265H: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 90381, 1 star); p.R265L: Uncertain_significance (ClinVar VariationId 1928288, 2 stars); p.R265= (synonymous): Likely_benign (ClinVar VariationId 491730, 2 stars)
PP1Cosegregation with disease
ClinVar submission reports cosegregation with disease (PP1); SCV000592379: In one family the variant was shown to segregate with disease in 4 affected individuals with Lynch syndrome (two were obligate carriers), and did not segregate in at least two unaffected individuals, increasing the likelihood this variant is pathogenic.
PP3Computational evidence supports damaging effect
Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — strong evidence (PP3); Splicing verdict: not pathogenic; Germline computational verdict: pathogenic (Strong)
PP5Reputable source reports pathogenic
ClinVar ≥3 stars pathogenic — very strong (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 3 star(s). ClinVar submissions strongly and reliably favor pathogenicity (10/10 total P/LP)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000249.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

MLH1 NM_000249.4
MANE Select
HGVSc / HGVSpc.793C>Ap.Arg265Ser
Exon rankExon 10 of 19
missensesplice_region
Prot: NP_000240.1
MLH1 NM_001354628.2
HGVSc / HGVSpc.793C>Ap.Arg265Ser
Exon rankExon 10 of 18
missensesplice_region
Prot: NP_001341557.1
MLH1 NM_001354629.2
HGVSc / HGVSpc.694C>Ap.Arg232Ser
Exon rankExon 9 of 18
missensesplice_region
Prot: NP_001341558.1

Ensembl Transcripts

MLH1 ENST00000231790.8
MANE Select
HGVSc / HGVSpc.793C>Ap.Arg265Ser
Exon rankExon 10 of 19
missensesplice_region
Prot: ENSP00000231790
MLH1 ENST00000458205.7
TSL:1
HGVSc / HGVSpc.70C>Ap.Arg24Ser
Exon rankExon 11 of 20
missensesplice_region
Prot: ENSP00000402667
MLH1 ENST00000931189.2
HGVSc / HGVSpc.793C>Ap.Arg265Ser
Exon rankExon 10 of 19
missensesplice_region
Prot: ENSP00000601248

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 5 sources
GnomAD3 genomes
Cov:32
GnomAD2 exomes
AF: 0.00000398
AC:1
AN:251460
GnomAD4 exome
Cov:31
GnomAD4 genome
Cov:32
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.00
AC:0
Hom:0
AN:57126
Showing 5 sources

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
2
-
-
Colorectal cancer, hereditary nonpolyposis, type 2 (2)
2
-
-
Lynch syndrome (2)
1
-
-
Carcinoma of colon (1)
1
-
-
Hereditary cancer-predisposing syndrome (1)
1
-
-
Hereditary nonpolyposis colon cancer (1)
1
-
-
Hereditary nonpolyposis colorectal neoplasms (1)
1
-
-
Lynch-like syndrome (1)
1
-
-
not provided (1)

Computational Scores

AlphaGenome AVI
Pathogenic50
AlphaMissense
Pathogenic1.0
BayesDel_addAF
Pathogenic0.57D
BayesDel_noAF
Pathogenic0.59
CADD
Pathogenic32
DANN
Uncertain1.0
DEOGEN2
Pathogenic0.90D
Eigen
Pathogenic1.1
Eigen_PC
Pathogenic1.0
FATHMM_MKL
Pathogenic1.0D
FuncVEP CTI
Pathogenic1.0
GPN-Star LLR
N/A-9.7
GPN-Star score
N/A9.7
LIST_S2
Pathogenic0.98D
M_CAP
Pathogenic0.77D
MetaRNN
Pathogenic0.99D
MetaSVM
Pathogenic0.94D
Mutation Taster
N/A0/100disease causing (ClinVar)
MutationAssessor
Pathogenic4.8H
PhyloP100
Uncertain7.3
popEVE
Benign-4.0
PrimateAI
Uncertain0.66T
PROVEAN
Pathogenic-5.9D
RBP_binding_hub_radar
N/A0.0
RBP_regulation_power_radar
N/A1.7
REVEL
Pathogenic0.98
Sift
Pathogenic0.0D
Sift4G
Pathogenic0.0D
Varity_R
N/A0.99
VESM-3B
Benign-13
Showing 30 of 30 scores

Splicing Scores

Pangolin (max)
Uncertain0.50
Pangolin loss
Pathogenic0.50
Position offset: -2
SpliceAI score (max)
Benign0.19
Details are displayed if max score is > 0.2
Splicevardb
N/A3.0
Showing 4 of 4 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

dbSNP: rs63751194;
hg19: chr3-37058999;
COSMIC: COSV109407253;
COSMIC: COSV109407253;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.